These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2362109)

  • 1. Erythromycin in chronic intestinal pseudo-obstruction.
    Berger SA; Keshavarzian A; DeMeo MT; Mobarhan S
    J Clin Gastroenterol; 1990 Jun; 12(3):363. PubMed ID: 2362109
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of erythromycin in chronic idiopathic intestinal pseudo-obstruction.
    Minami T; Nishibayashi H; Shinomura Y; Matsuzawa Y
    J Gastroenterol; 1996 Dec; 31(6):855-9. PubMed ID: 9027652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response.
    Emmanuel AV; Shand AG; Kamm MA
    Aliment Pharmacol Ther; 2004 Mar; 19(6):687-94. PubMed ID: 15023171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction.
    Verne GN; Eaker EY; Hardy E; Sninsky CA
    Dig Dis Sci; 1995 Sep; 40(9):1892-901. PubMed ID: 7555439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effective treatment in combination with erythromycin and cisapride for chronic idiopathic intestinal pseudo-obstruction (CIIP)].
    Yanagisawa M; Kusano M; Doi I; Motegi K; Nakamura K; Kawamura O; Mori M; Sekiguchi T
    Nihon Shokakibyo Gakkai Zasshi; 1998 Sep; 95(9):1022-6. PubMed ID: 9785893
    [No Abstract]   [Full Text] [Related]  

  • 6. The Use of Pyridostigmine in a Child With Chronic Intestinal Pseudo-Obstruction.
    Choudhury A; Rahyead A; Kammermeier J; Mutalib M
    Pediatrics; 2018 Apr; 141(Suppl 5):S404-S407. PubMed ID: 29610160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effective treatment in combination with erythromycin and cisapride for chronic idiopathic intestinal pseudo-obstruction (CIIP)].
    Torii A
    Nihon Shokakibyo Gakkai Zasshi; 1999 Mar; 96(3):318-9. PubMed ID: 10214084
    [No Abstract]   [Full Text] [Related]  

  • 8. [The potentials of erythromycin derivatives in the treatment of gastrointestinal motility disorders].
    Peeters TL
    Z Gesamte Inn Med; 1991 Aug; 46(10-11):349-54. PubMed ID: 1926941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intravenous erythromycin on postoperative ileus.
    Bonacini M; Quiason S; Reynolds M; Gaddis M; Pemberton B; Smith O
    Am J Gastroenterol; 1993 Feb; 88(2):208-11. PubMed ID: 8424422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic intestinal pseudoobstruction: report of four pediatric patients.
    Dalgiç B; Sari S; Doğan I; Unal S
    Turk J Gastroenterol; 2005 Jun; 16(2):93-7. PubMed ID: 16252200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Small bowel pseudo-obstruction revealing an early scleroderma. Long-term efficacy of octreotide and erythromycin].
    Lecomte T; Cavicchi M; Delchier JC
    Gastroenterol Clin Biol; 2000 Mar; 24(3):361-3. PubMed ID: 10804347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of pseudo-obstruction in children.
    Rudolph CD; Glassman MS
    Am J Gastroenterol; 1993 Jun; 88(6):802-6. PubMed ID: 8503372
    [No Abstract]   [Full Text] [Related]  

  • 13. [Octreotide in intestinal pseudo-obstruction?].
    Layer P; Holtmann G
    Z Gastroenterol; 1992 May; 30(5):346-7. PubMed ID: 1632118
    [No Abstract]   [Full Text] [Related]  

  • 14. Cisapride in the treatment of chronic intestinal pseudo-obstruction.
    Reyntjens A; Verlinden M; Schuermans V
    Z Gastroenterol; 1990 Apr; 28 Suppl 1():79-84; discussion 92-3. PubMed ID: 2192509
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacological regulation of intestinal motility in patients with injuries].
    Shangaĭ VA; Lebedinets VN
    Ortop Travmatol Protez; 1984 Feb; (2):41-3. PubMed ID: 6546980
    [No Abstract]   [Full Text] [Related]  

  • 16. Antroduodenal motor effects of intravenous erythromycin in children with abnormalities of gastrointestinal motility.
    Cucchiara S; Minella R; Scoppa A; Emiliano M; Calabrese F; Az-Zeqeh N; Rea B; Salvia G
    J Pediatr Gastroenterol Nutr; 1997 Apr; 24(4):411-8. PubMed ID: 9144124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intestinal pseudo-obstruction].
    Heilmann G; Erckenbrecht JF
    Ther Umsch; 1994 Mar; 51(3):208-15. PubMed ID: 8160167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical recovery of chronic intestinal pseudo-obstruction with cisapride in a complex pediatric patient.
    Cameron JC; Vaillancourt R; Major-Cook N; Boland M; Zucker M; Lariviere D
    Am J Hosp Palliat Care; 2013 Jun; 30(4):403-5. PubMed ID: 22964344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sequential erythromycin and octreotide on antroduodenal manometry.
    Di Lorenzo C; Lucanto C; Flores AF; Idries S; Hyman PE
    J Pediatr Gastroenterol Nutr; 1999 Sep; 29(3):293-6. PubMed ID: 10467994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythromycin in neonatal postoperative intestinal dysmotility.
    Simkiss DE; Adams IP; Myrdal U; Booth IW
    Arch Dis Child Fetal Neonatal Ed; 1994 Sep; 71(2):F128-9. PubMed ID: 7979468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.